CoChat
Sign Up
Cited by 395Infant Development and Preterm CareNeonatal and fetal brain pathologyNeonatal Health and Biochemistry

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years

Open access
McKinlay, Christopher J. D., Alsweiler, Jane M., Anstice, Nicola S., Burakevych, Nataliia, Chakraborty, Arijit, Chase, J. Geoffrey, Gamble, Gregory D., Harris, Deborah L., Jacobs, Robert J., Jiang, Yannan, Paudel, Nabin, San Diego, Ryan J., Thompson, Benjamin, Wouldes, Trecia A., Harding, Jane E., for the Children With Hypoglycemia and Their Later Development (CHYLD) Study Team·2017·JAMA Pediatrics
DOI 10.1001/jamapediatrics.2017.1579PMC PMC5710616
Open this paper in CoChat — free account

Abstract

Importance: Hypoglycemia is common during neonatal transition and may cause permanent neurological impairment, but optimal intervention thresholds are unknown. Objective: To test the hypothesis that neurodevelopment at 4.5 years is related to the severity and frequency of neonatal hypoglycemia. Design, Setting, and Participants: The Children With Hypoglycemia and Their Later Development (CHYLD) Study is a prospective cohort investigation of moderate to late preterm and term infants born at risk of hypoglycemia. Clinicians were masked to neonatal interstitial glucose concentrations; outcome assessors were masked to neonatal glycemic status. The setting was a regional perinatal center in Hamilton, New Zealand. The study was conducted from December 2006 to November 2010. The dates of the follow-up were September 2011 to June 2015. Participants were 614 neonates born from 32 weeks' gestation with at least 1 risk factor for hypoglycemia, including diabetic mother, preterm, small, large, or acute illness. Blood and masked interstitial glucose concentrations were measured for up to 7 days after birth. Infants with hypoglycemia (whole-blood glucose concentration <47 mg/dL) were treated to maintain blood glucose concentration of at least 47 mg/dL. Exposures: Neonatal hypoglycemic episode, defined as at least 1 consecutive blood glucose concentration less than 47 mg/dL, a severe episode (<36 mg/dL), or recurrent (≥3 episodes). An interstitial episode was defined as an interstitial glucose concentration less than 47 mg/dL for at least 10 minutes. Main Outcomes and Measures: Cognitive function, executive function, visual function, and motor function were assessed at 4.5 years. The primary outcome was neurosensory impairment, defined as poor performance in one or more domains. Results: In total, 477 of 604 eligible children (79.0%) were assessed. Their mean (SD) age at the time of assessment was 4.5 (0.1) years, and 228 (47.8%) were female. Those exposed to neonatal hypoglycemia (280 [58.7%]) did not have increased risk of neurosensory impairment (risk difference [RD], 0.01; 95% CI, -0.07 to 0.10 and risk ratio [RR], 0.96; 95% CI, 0.77 to 1.21). However, hypoglycemia was associated with increased risk of low executive function (RD, 0.05; 95% CI, 0.01 to 0.10 and RR, 2.32; 95% CI, 1.17 to 4.59) and visual motor function (RD, 0.03; 95% CI, 0.01 to 0.06 and RR, 3.67; 95% CI, 1.15 to 11.69), with highest risk in children exposed to severe, recurrent, or clinically undetected (interstitial episodes only) hypoglycemia. Conclusions and Relevance: Neonatal hypoglycemia was not associated with increased risk of combined neurosensory impairment at 4.5 years but was associated with a dose-dependent increased risk of poor executive function and visual motor function, even if not detected clinically, and may thus influence later learning. Randomized trials are needed to determine optimal screening and intervention thresholds based on assessment of neurodevelopment at least to school age.

Overview

Integrity signals

Registry

Crossref · 10.1001/jamapediatrics.2017.1579

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 34 references

1 of the 34 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 301–395 of 395

Related

See all

Metadata

Authors
McKinlay, C. J. D., Alsweiler, J. M., Anstice, N. S., Burakevych, N., Chakraborty, A., Chase, J. G., Gamble, G. D., Harris, D. L., Jacobs, R. J., Jiang, Y., Paudel, N., San Diego, R. J., Thompson, B., Wouldes, T. A., Harding, J. E., & for the Children With Hypoglycemia and Their Later Development (CHYLD) Study Team
Affiliations
  • University of Auckland (NZ)
  • University of Waterloo (CA)
  • University of Canterbury (NZ)
  • Liggins Institute, The University of Auckland, Auckland, New Zealand
  • Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand
Corresponding author
Harding, Jane E.
ORCID
Venue
JAMA Pediatrics
Publisher
American Medical Association (AMA)
Published
2017-10-01
Volume
171
Issue
10
Pages
972
ISSN
  • 1072-4710 (ISSN-L)
  • 2168-6203
DOI
10.1001/jamapediatrics.2017.1579
PMC
PMC5710616
OpenAlex
W2744358282
Cited by
395
References
34
Citations by year
2026: 35 · 2025: 29 · 2024: 48 · 2023: 51 · 2022: 50 · 2021: 53 · 2020: 54 · 2019: 37 · 2018: 27 · 2017: 10
FWCI
38.23
Type
journal article
Language
en
Open access
Locations
  • Archives of Pediatrics and Adolescent Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ResearchSpace (University of Auckland) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Development and Preterm Care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
Keywords
neonatal hypoglycemia, neurodevelopmental outcomes, neurosensory disturbance, preterm infants, executive function, motor function, visual function, cognitive function, diabetes in pregnancy, neonatal intensive care
MeSH terms
Blood Glucose, Child Development, Child, Preschool, Female, Humans, Hypoglycemia, Infant, Infant, Newborn, Infant, Newborn, Diseases, Male, New Zealand, Prospective Studies, Cohort Studies, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review